Maria A. De Stefano

Naples, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 26 publications

Type 2 Deiodinase in Cancer-Associated Fibroblasts is Required to Sustain Growth of Poorly and Undifferentiated Thyroid Cancer.

Type 2 Deiodinase in Cancer-Associated Fibroblasts is Required to Sustain Growth of Poorly and Undifferentiated Thyroid Cancer.

Journal: Thyroid : official journal of the American Thyroid Association

Published: December 03, 2025

Therapeutic p63 isoform switching rescues epidermal defects in AEC syndrome.

Therapeutic p63 isoform switching rescues epidermal defects in AEC syndrome.

Journal: Molecular therapy : the journal of the American Society of Gene Therapy

Published: August 13, 2025

The unique signature of tyrosine kinase inhibitor-induced hypothyroidism.

The unique signature of tyrosine kinase inhibitor-induced hypothyroidism.

Journal: The lancet. Diabetes & endocrinology

Published: May 17, 2025

Type 2 deiodinase-dependent surge in thyroid hormone controls muscle stem cell quiescence and self-renewal.

Type 2 deiodinase-dependent surge in thyroid hormone controls muscle stem cell quiescence and self-renewal.

Journal: The Journal of clinical investigation

Published: April 25, 2025

FT3 and FT3/FT4 ratio are decreased and not compensated by levothyroxine treatment in TKI-treated thyroid cancer patients.

FT3 and FT3/FT4 ratio are decreased and not compensated by levothyroxine treatment in TKI-treated thyroid cancer patients.

Journal: Endocrine-related cancer

Published: November 29, 2024

Did selective kinase inhibitors change the management of patients with radioiodine-refractory thyroid cancer?

Did selective kinase inhibitors change the management of patients with radioiodine-refractory thyroid cancer?

Journal: European thyroid journal

Published: October 15, 2024

Type 2 Deiodinase Promotes Fatty Adipogenesis in Muscle Fibroadipogenic Progenitors From Adult Male Mice.

Type 2 Deiodinase Promotes Fatty Adipogenesis in Muscle Fibroadipogenic Progenitors From Adult Male Mice.

Journal: Endocrinology

Published: September 03, 2024

D898_E901 RET Deletion Is Oncogenic, Responds to Selpercatinib, and Treatment Resistance Can Arise Via RET-Independent Mechanisms.

D898_E901 RET Deletion Is Oncogenic, Responds to Selpercatinib, and Treatment Resistance Can Arise Via RET-Independent Mechanisms.

Journal: JCO precision oncology

Published: August 03, 2023

Type 2 Deiodinase Thr92Ala Polymorphism and Aging Are Associated with a Decreased Pituitary Sensitivity to Thyroid Hormone.

Type 2 Deiodinase Thr92Ala Polymorphism and Aging Are Associated with a Decreased Pituitary Sensitivity to Thyroid Hormone.

Journal: Thyroid : official journal of the American Thyroid Association

Published: January 21, 2023

Vandetanib downregulates type 2 deiodinase in fibro/adipogenic progenitors.

Vandetanib downregulates type 2 deiodinase in fibro/adipogenic progenitors.

Journal: Endocrine-related cancer

Published: January 10, 2023

Altered Thyroid Feedback Loop in Klinefelter Syndrome: From Infancy Through the Transition to Adulthood.

Altered Thyroid Feedback Loop in Klinefelter Syndrome: From Infancy Through the Transition to Adulthood.

Journal: The Journal of clinical endocrinology and metabolism

Published: January 01, 2023

Combination of Lenvatinib and Pembrolizumab as Salvage Treatment for Paucicellular Variant of Anaplastic Thyroid Cancer: A Case Report.

Combination of Lenvatinib and Pembrolizumab as Salvage Treatment for Paucicellular Variant of Anaplastic Thyroid Cancer: A Case Report.

Journal: Current oncology (Toronto, Ont.)

Published: October 14, 2021

Showing 1-12 of 26

Last Updated: 09/26/2026